{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:15655"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:15655","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Idiopathic intracranial hypertension: empowering patients and physicians to advance patient care through research","abstract":"Idiopathic Intracranial Hypertension (IIH) is a condition characterised by raised intracranial pressure (ICP), papilloedema, with risk of permanent visual loss and chronic headaches. It predominately affects young women and is associated with obesity. The incidence of IIH is increasing as obesity rates increase, as confirmed in England analysing the Hospital Episode Statistic dataset. Both physicians and patients are central to improving care and advancing knowledge. The first IIH consensus guidelines brought together a multidisciplinary group. A priority setting partnership was subsequently conducted and found a key knowledge gap that the Idiopathic Intracranial Hypertension Weight Trial (IIHWT) aimed to address. The IIHWT found that bariatric surgery provided sustained ICP reduction and weight loss for up to two years. The per protocol analysis determined how much body weight should be lost to ensure disease remission. The IIHWT headache analysis uniquely found that ICP was correlated with headache outcomes. The pointwise visual field analysis demonstrated what could be a meaningful change in an IIH trial population. The direct impact of this work has afforded a change in national guidelines for people living with obesity and IIH. The cumulative knowledge gained has now delivered the first international multidisciplinary research guideline for IIH.","abstract_html":"Idiopathic Intracranial Hypertension (IIH) is a condition characterised by raised intracranial pressure (ICP), papilloedema, with risk of permanent visual loss and chronic headaches. It predominately affects young women and is associated with obesity. The incidence of IIH is increasing as obesity rates increase, as confirmed in England analysing the Hospital Episode Statistic dataset. Both physicians and patients are central to improving care and advancing knowledge. The first IIH consensus guidelines brought together a multidisciplinary group. A priority setting partnership was subsequently conducted and found a key knowledge gap that the Idiopathic Intracranial Hypertension Weight Trial (IIHWT) aimed to address. The IIHWT found that bariatric surgery provided sustained ICP reduction and weight loss for up to two years. The per protocol analysis determined how much body weight should be lost to ensure disease remission. The IIHWT headache analysis uniquely found that ICP was correlated with headache outcomes. The pointwise visual field analysis demonstrated what could be a meaningful change in an IIH trial population. The direct impact of this work has afforded a change in national guidelines for people living with obesity and IIH. The cumulative knowledge gained has now delivered the first international multidisciplinary research guideline for IIH.","abstract_has_math":false,"creators":["Mollan, Susan Patricia"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-12","date_published":"2024-12","updated_at":"2026-11-19T09:32:59Z","subjects":["RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry","RE Ophthalmology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000263144437"],"render_values":[{"text":"0000-0002-6314-4437","href":"https://orcid.org/0000-0002-6314-4437","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/15655/8/Mollan2024PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A15655","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Mollan, Susan Patricia"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000263144437"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-12-10"]},{"key":"dc:date.issued","label":"Date","values":["2024-12"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Metabolism and Systems Research"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/15655/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry","RE Ophthalmology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/15655/8/Mollan2024PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Idiopathic Intracranial Hypertension (IIH) is a condition characterised by raised intracranial pressure (ICP), papilloedema, with risk of permanent visual loss and chronic headaches. It predominately affects young women and is associated with obesity. The incidence of IIH is increasing as obesity rates increase, as confirmed in England analysing the Hospital Episode Statistic dataset. Both physicians and patients are central to improving care and advancing knowledge. The first IIH consensus guidelines brought together a multidisciplinary group. A priority setting partnership was subsequently conducted and found a key knowledge gap that the Idiopathic Intracranial Hypertension Weight Trial (IIHWT) aimed to address. The IIHWT found that bariatric surgery provided sustained ICP reduction and weight loss for up to two years. The per protocol analysis determined how much body weight should be lost to ensure disease remission. The IIHWT headache analysis uniquely found that ICP was correlated with headache outcomes. The pointwise visual field analysis demonstrated what could be a meaningful change in an IIH trial population. The direct impact of this work has afforded a change in national guidelines for people living with obesity and IIH. The cumulative knowledge gained has now delivered the first international multidisciplinary research guideline for IIH."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Idiopathic intracranial hypertension: empowering patients and physicians to advance patient care through research"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Mollan, Susan Patricia"],"dc:date":["2024-12-10"],"dc:date.issued":["2024-12"],"dc:description.abstract":["Idiopathic Intracranial Hypertension (IIH) is a condition characterised by raised intracranial pressure (ICP), papilloedema, with risk of permanent visual loss and chronic headaches. It predominately affects young women and is associated with obesity. The incidence of IIH is increasing as obesity rates increase, as confirmed in England analysing the Hospital Episode Statistic dataset. Both physicians and patients are central to improving care and advancing knowledge. The first IIH consensus guidelines brought together a multidisciplinary group. A priority setting partnership was subsequently conducted and found a key knowledge gap that the Idiopathic Intracranial Hypertension Weight Trial (IIHWT) aimed to address. The IIHWT found that bariatric surgery provided sustained ICP reduction and weight loss for up to two years. The per protocol analysis determined how much body weight should be lost to ensure disease remission. The IIHWT headache analysis uniquely found that ICP was correlated with headache outcomes. The pointwise visual field analysis demonstrated what could be a meaningful change in an IIH trial population. The direct impact of this work has afforded a change in national guidelines for people living with obesity and IIH. The cumulative knowledge gained has now delivered the first international multidisciplinary research guideline for IIH."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/15655/8/Mollan2024PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Metabolism and Systems Research"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/15655/"],"dc:subject":["RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry","RE Ophthalmology"],"dcterms:accessrights":["public"],"dc:title":["Idiopathic intracranial hypertension: empowering patients and physicians to advance patient care through research"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"],"person:identifier.orcid":["0000000263144437"]},"updated_at":"2026-11-19T09:32:59Z"}